We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SGRY market cap is 3.27B. The company's latest EPS is USD -0.0936 and P/E is -275.21.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 674.1M | 741.8M | 721.2M | 768.1M | 772.1M |
| Operating Income | 90.8M | 117.8M | 77.5M | 95.2M | 75.6M |
| Net Income | -4.9M | -1M | -12.4M | -15.5M | -31.7M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.83B | 1.91B | 2.28B | 2.59B | 2.75B |
| Operating Income | 219.9M | 188.7M | 304.4M | 371.2M | 357.9M |
| Net Income | -110.5M | -155.6M | -81.2M | -54.6M | -11.9M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.78B | 6.88B | 6.98B | 7.49B | 7.53B |
| Total Liabilities | 3.46B | 3.51B | 3.61B | 3.87B | 3.99B |
| Total Equity | 2.99B | 3.03B | 3.04B | 3.18B | 3.11B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 5.02B | 5.41B | 6.12B | 6.68B | 6.88B |
| Total Liabilities | 3.32B | 3.79B | 3.82B | 3.4B | 3.51B |
| Total Equity | 983.4M | 882.1M | 1.97B | 2.94B | 3.03B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 231.2M | 293.8M | 40.7M | 123.5M | 188.7M |
| Investing | -167.5M | -225.6M | -83.1M | -327.2M | -376.8M |
| Financing | -110.6M | -155.2M | 31.7M | 221.3M | 214M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 129.5M | 246.9M | 87.1M | 158.8M | 293.8M |
| Investing | -85.2M | -88.4M | -331.7M | -307.9M | -225.6M |
| Financing | -135.9M | 66.7M | 316.3M | 42.1M | -155.2M |
| Market Cap | 3.27B |
| Price to Earnings Ratio | -275.21 |
| Price to Sales Ratio | 1.19 |
| Price to Cash Ratio | 16.72 |
| Price to Book Ratio | 0.97 |
| Dividend Yield | - |
| Shares Outstanding | 127.11M |
| Average Volume (1 week) | 1.15M |
| Average Volume (1 Month) | 1.86M |
| 52 Week Change | -24.09% |
| 52 Week High | 35.295 |
| 52 Week Low | 19.55 |
| Spread (Intraday) | 1.04 (3.95%) |
| Company Name | Surgery Partners Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.surgerypartners.com |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
